- Diabetes
- Latent Autoimmune Diabetes in Adults: Current Status and New Horizons
-
Paolo Pozzilli, Silvia Pieralice
-
Endocrinol Metab. 2018;33(2):147-159. Published online June 21, 2018
-
DOI: https://doi.org/10.3803/EnM.2018.33.2.147
-
-
14,077
View
-
371
Download
-
52
Web of Science
-
46
Crossref
-
Abstract
PDFPubReader ePub
Autoimmune diabetes is a heterogeneous disease which can arise at any age. Subjects with adult-onset autoimmune diabetes who do not necessitate insulin-therapy for at least 6 months after diagnosis are demarcated as having latent autoimmune diabetes in adults (LADA). This condition is more heterogeneous than young-onset autoimmune diabetes and shares clinical and metabolic characteristics with both type 2 and type 1 diabetes. Patients with LADA are considered by having highly variable β-cell destruction, different degrees of insulin resistance and heterogeneous titre and pattern of islet autoantibody, suggesting different pathophysiological pathways partially explaining the heterogeneous phenotypes of LADA. To date the heterogeneity of LADA does not allow to establish a priori treatment algorithm and no specific guidelines for LADA therapy are available. These subjects are mostly treated as affected by type 2 diabetes, a factor that might lead to the progression to insulin-dependency quickly. A personalised medicine approach is necessary to attain optimal metabolic control and preserve β-cell function to decrease the risk of long-term diabetes complications. Recent data concerning the use of oral antidiabetic agents as dipeptidyl peptidase 4 inhibitors and glucagon-like peptide 1 receptor agonists indicate up-and-coming results in term of protect C-peptide levels and improving glycaemic control. This review summarises current knowledge on LADA, emphasising controversies regarding its pathophysiology and clinical features. Moreover, we discuss data available about novel therapeutic approaches that can be considered for prevention of β-cell loss in LADA.
-
Citations
Citations to this article as recorded by
- Utility of Fasting C-Peptide for the Diagnostic Differentiation of Patients with Type 1, Type 2 Diabetes, MODY, and LADA
Ricardo Alemán-Contreras, Rita A. Gómez-Díaz, Maura E. Noyola-García, Rafael Mondragón-González, Niels Wacher, Aldo Ferreira-Hermosillo Life.2024; 14(5): 550. CrossRef - Drug candidates and potential targets of Curculigo spp. compounds for treating diabetes mellitus based on network pharmacology, molecular docking and molecular dynamics simulation
Abdul Halim Umar, Diah Ratnadewi, Mohamad Rafi, Yohana Caecilia Sulistyaningsih, Hamim Hamim, Wisnu Ananta Kusuma Journal of Biomolecular Structure and Dynamics.2023; 41(17): 8544. CrossRef - Development and validation of a clinical score for identifying patients with high risk of latent autoimmune adult diabetes (LADA): The LADA primary care-protocol study
Pilar Vich-Pérez, Juan Carlos Abánades-Herranz, Gustavo Mora-Navarro, Ángela María Carrasco-Sayalero, Miguel Ángel Salinero-Fort, Ignacio Sevilla-Machuca, Mar Sanz-Pascual, Cristina Álvarez Hernández-Cañizares, Carmen de Burgos-Lunar, Vijayaprakash Suppia PLOS ONE.2023; 18(2): e0281657. CrossRef - Diagnostic Dilemmas and Current Treatment Approaches in Latent Onset
Autoimmune Diabetes in Adults: A Concise Review
Lakshmi Chandran, Ankul Singh S., Chitra Vellapandian Current Diabetes Reviews.2023;[Epub] CrossRef - Characteristics of adult-onset auto-immune type 1 diabetes
Faten Hadj Kacem, Ameni Jerbi, Bibi Twaheerah Allymamod, Wafa Bel Abed, Mouna Mnif, Nadia Charfi, Mouna Elleuch, Nabila Rekik, Hatem Masmoudi, Mohamed Abid The American Journal of the Medical Sciences.2023; 366(1): 49. CrossRef - The role of cholecalciferol deficiency in the development of latent autoimmune diabetes in adults
I.O. Tsaryk, N.V. Pashkovska INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2023; 19(4): 259. CrossRef - Newly diagnosed type 1 diabetes mellitus in a human immunodeficiency virus-infected patient with antiretroviral therapy-induced immune reconstitution inflammatory syndrome: a case report
Min-ChunYeh, Han-Chuan Chuang, Shuen-Fu Weng, Chung-Huei Hsu, Chen-Ling Huang, Yu-Pei Lin, Yan-Yu Lin, Yu-Shan Hsieh BMC Infectious Diseases.2023;[Epub] CrossRef - A Review on Latent Autoimmune Diabetes in Adults
Vijay Ravikumar, Ariba Ahmed, Ashish Anjankar Cureus.2023;[Epub] CrossRef - Exploring Immune Therapies in a Twin Case of Latent Autoimmune Diabetes in Adults and Generalized Granuloma Annulare
Brian W. Connor, Sarah E.B. Smith, Andrea Kalus Clinical Diabetes.2023; 41(4): 583. CrossRef - Innate immunity in latent autoimmune diabetes in adults
Juan Huang, James Alexander Pearson, F. Susan Wong, Li Wen, Zhiguang Zhou Diabetes/Metabolism Research and Reviews.2022;[Epub] CrossRef - Endocrine Manifestations and New Developments in Mitochondrial Disease
Yi Shiau Ng, Albert Zishen Lim, Grigorios Panagiotou, Doug M Turnbull, Mark Walker Endocrine Reviews.2022; 43(3): 583. CrossRef - Two Fifth-Generation Fighter Pilots Discovered with Latent Autoimmune Diabetes
Joe X. Zhang, Jacob Berry, Nathan M. Kim, Justin J. Gray, Savannah Fotheringham, Tom J. Sauerwein Aerospace Medicine and Human Performance.2022; 93(2): 106. CrossRef - A Case of Late Diagnosis of Latent Autoimmune Diabetes in Adults
Joana R Costa, Ana Mestre, Mariana S Miranda, Frederica H Ferreira, Yahia Abuowda Cureus.2022;[Epub] CrossRef - Class I MHC Polymorphisms Associated with Type 2 Diabetes in the Mexican Population
Paola Mendoza-Ramírez, Mildred Alejandra López-Olaiz, Adriana Lizeth Morales-Fernández, María Isabel Flores-Echiveste, Antonio de Jesus Casillas-Navarro, Marco Andrés Pérez-Rodríguez, Felipe de Jesús Orozco-Luna, Celso Cortés-Romero, Laura Yareni Zuñiga, Genes.2022; 13(5): 772. CrossRef - Efficacy and safety of sitagliptin and insulin for latent autoimmune diabetes in adults: A systematic review and meta‐analysis
Tong Lin, Yinhe Cai, Liting Tang, Youwei Lian, Min Liu, Chaonan Liu Journal of Diabetes Investigation.2022; 13(9): 1506. CrossRef - Partial Remission of Diabetes in a Young Adult While Testing Positive for Several Islet Cell Autoantibodies: A Case Report, Literature Review, and Patient Perspective
Samson O Oyibo Cureus.2022;[Epub] CrossRef - Latent Autoimmune Diabetes in Adults and Metabolic Syndrome—A Mini Review
Niansi Pan, Shimei Yang, Xiaohong Niu Frontiers in Endocrinology.2022;[Epub] CrossRef - Prevalence and factors associated with latent autoimmune diabetes in adults (LADA): a cross-sectional study
Anselmo M. Manisha, Aminiel R. Shangali, Sayoki G. Mfinanga, Erasto V. Mbugi BMC Endocrine Disorders.2022;[Epub] CrossRef - Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto’s thyroiditis: a case report
Maria Xenou, Ioannis Zoupas, Dimitrios Lygnos, Evangelos Fousteris Journal of Medical Case Reports.2022;[Epub] CrossRef - Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy
Jingyi Hu, Rong Zhang, Hailan Zou, Lingxiang Xie, Zhiguang Zhou, Yang Xiao Frontiers in Endocrinology.2022;[Epub] CrossRef - Adult-onset autoimmune diabetes
Raffaella Buzzetti, Ernesto Maddaloni, Jason Gaglia, R. David Leslie, F. Susan Wong, Bernhard O. Boehm Nature Reviews Disease Primers.2022;[Epub] CrossRef - Diagnostic camouflage: A case report on Latent autoimmune diabetics of adulthood
Sandhya kiran Neupane, Prakash Paudel Jaishi, Divyaa Koirala, Arjun Kandel, Prabhat Kiran Neupane Annals of Medicine and Surgery.2022; 82: 104699. CrossRef - A Mechanistic Insight on Phytoconstituents Delivering Hypoglycemic Activity: A Comprehensive Overview
Shraddha Singh Raghav, Bhavna Kumar, Neeraj Kumar Sethiya, Ankur Kaul Future Pharmacology.2022; 2(4): 511. CrossRef - Diagnostic dilemmas in young onset diabetes mellitus
Avijit Saha, Parna Roy Annals of Medical Science and Research.2022; 1(3): 111. CrossRef - Prevalence of diabetes-associated autoantibodies among patients presenting with type 2 diabetes and related metabolic differences
Fatemeh Moosaie, Neda Meftah, Niloofar Deravi, Kosar Abouhamzeh, Fatemeh Dehghani Firouzabadi, Pegah Khaloo, Mohammad Ali Mansournia, Seyede Marzie Fatemi Abhari, Manouchehr Nakhjavani, Alireza Esteghamati Primary Care Diabetes.2021; 15(1): 169. CrossRef - The association of human leukocyte antigen class II (HLA II) haplotypes with the risk of Latent autoimmune diabetes of adults (LADA): Evidence based on available data
Wenjun Chen, Xinlin Chen, Minting Zhang, Zunnan Huang Gene.2021; 767: 145177. CrossRef - A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes
Thomas Forst, Pratik Choudhary, Doron Schneider, Bruno Linetzky, Paolo Pozzilli Diabetes/Metabolism Research and Reviews.2021;[Epub] CrossRef - Bewusstseinsstörung, Tachypnoe und Tachykardie bei einem 71-jährigen Patienten mit Diabetes mellitus Typ 2
S. Großmann, U. Hoffmann, C. Girlich Der Internist.2021; 62(6): 672. CrossRef - Good Glycemic Outcomes Following Bariatric Surgery Among Patients With Type 2 Diabetes, Obesity, and Low-Titer GAD Antibodies
Ruveena Kaur, David Kim, Richard Cutfield, Michael Booth, Lindsay Plank, Rinki Murphy Diabetes Care.2021; 44(2): 607. CrossRef - Slowly evolving, immune-mediated diabetes in 14-year-old patient: a case report
M. R. Ragimov, D. D. Omelchuk, L. I. Ibragimova, O. S. Derevyanko, T. V. Nikonova Diabetes mellitus.2021; 24(1): 70. CrossRef - Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes
Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Susana Nogueira Diniz, Andrea Fabbri, Marco Infante International Immunopharmacology.2021; 95: 107518. CrossRef - Current view of diagnosis and treatment of latent autoimmune diabetes in adults
Jana Urbanová, Ludmila Brunerová, Jana Malinovská, Barbora Pelechová, Ludmila Koberová, Jan Brož Vnitřní lékařství.2021; 67(2): 97. CrossRef - Alpha‐amylase as molecular target for treatment of diabetes mellitus: A comprehensive review
Navjot Kaur, Vanktesh Kumar, Surendra Kumar Nayak, Pankaj Wadhwa, Paranjit Kaur, Sanjeev Kumar Sahu Chemical Biology & Drug Design.2021; 98(4): 539. CrossRef - CLINICAL AND IMMUNOLOGICAL ASPECTS OF VERIFICATION OF LATENT AUTOIMMUNE DIABETES IN ADULTS AT EARLY STAGES OF DISEASE MANIFESTATION
Tetiana М. Tykhonova, Igor V. Belozоrov, Nadiya Ye. Barabash, Larysa O. Martymianova Wiadomości Lekarskie.2021; 74(7): 1707. CrossRef - Bacillus Calmette-Guerin 's beneficial impact on glucose metabolism: Evidence for broad based applications
Gabriella F. Shpilsky, Hiroyuki Takahashi, Anna Aristarkhova, Michele Weil, Nathan Ng, Kacie J. Nelson, Amanda Lee, Hui Zheng, Willem M. Kühtreiber, Denise L. Faustman iScience.2021; 24(10): 103150. CrossRef - Multicentre analysis of hyperglycaemic hyperosmolar state and diabetic ketoacidosis in type 1 and type 2 diabetes
S. R. Tittel, K. M. Sondern, M. Weyer, T. Poeplau, B. M. Sauer, M. Schebek, K.-H. Ludwig, F. Hammer, E. Fröhlich-Reiterer, R. W. Holl Acta Diabetologica.2020; 57(10): 1245. CrossRef - Pancreas Pathology of Latent Autoimmune Diabetes in Adults (LADA) in Patients and in a LADA Rat Model Compared With Type 1 Diabetes
Anne Jörns, Dirk Wedekind, Joachim Jähne, Sigurd Lenzen Diabetes.2020; 69(4): 624. CrossRef - Past, present and future of latent autoimmune diabetes in adults
Bingwen Liu, Yufei Xiang, Zhenqi Liu, Zhiguang Zhou Diabetes/Metabolism Research and Reviews.2020;[Epub] CrossRef - Adult-onset autoimmune diabetes in 2020: An update
Ernesto Maddaloni, Chiara Moretti, Carmen Mignogna, Raffaella Buzzetti Maturitas.2020; 137: 37. CrossRef - Altered peripheral nerve structure and function in latent autoimmune diabetes in adults
Tushar Issar, Aimy Yan, Natalie C. G. Kwai, Ann M. Poynten, Adeniyi A. Borire, Ria Arnold, Arun V. Krishnan Diabetes/Metabolism Research and Reviews.2020;[Epub] CrossRef - Low rate of latent autoimmune diabetes in adults (LADA) in patients followed for type 2 diabetes: A single center’s experience in Turkey
Abbas Ali Tam, Didem Ozdemir, Nagihan Bestepe, Fatma Dilek Dellal, Muhammet Cuneyt Bilginer, Sevgul Faki, Cemile Bicer, Reyhan Ersoy, Bekir Cakir Archives of Endocrinology and Metabolism.2020;[Epub] CrossRef - Distinguishing between type 1 and type 2 diabetes
Alexandra E Butler, David Misselbrook BMJ.2020; : m2998. CrossRef - Exogenous Insulin Injection-Induced Stiff-Person Syndrome in a Patient With Latent Autoimmune Diabetes: A Case Report and Literature Review
Yi-Yin Lee, Cheng-Wei Lin, I-Wen Chen Frontiers in Endocrinology.2020;[Epub] CrossRef - Investigating optimal β‐cell‐preserving treatment in latent autoimmune diabetes in adults: Results from a 21‐month randomized trial
Ingrid K. Hals, Hanne Fiskvik Fleiner, Nina Reimers, Marianne C. Astor, Karin Filipsson, Zuheng Ma, Valdemar Grill, Anneli Björklund Diabetes, Obesity and Metabolism.2019; 21(10): 2219. CrossRef - Immunological and clinical characteristics of latent autoimmune diabetes in the elderly
Silvina Yohena, Alberto Penas‐Steinhardt, Clara Muller, Natalia I. Faccinetti, Gloria E. Cerrone, Silvia Lovecchio, Edgardo Ridner, Silvina Valdez, Gustavo Frechtel Diabetes/Metabolism Research and Reviews.2019;[Epub] CrossRef - Autoimmunity in latent autoimmune diabetes in adults
Alessandro P. Delitala AIMS Medical Science.2019; 6(2): 132. CrossRef
|